Drug Discovery: AI's Accelerated Pipeline

AI has dramatically reduced drug discovery timelines, with companies like Insilico Medicine advancing novel drug candidates to clinical trials in a fraction of the traditional time and cost.

来源

• Insilico Medicine announces developmental candidate benchmarks and timelines for novel therapeutics discovered using generative AI | EurekAlert!
• From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes - PMC
• Insilico Medicine provides benchmark timelines from its 22 AI-designed drug candidates
• From Start to Phase 1 in 30 Months | Insilico Medicine
• Insights to Innovation: Insilico Medicine AI-driven Practice Published on Springer Nature in Latest AI for Drug Discovery Volume

打开完整版